X0202 SCHEDULE 13G/A 0001104659-24-023663 0001256153 XXXXXXXX LIVE 6 COMMON STOCK, $0.001 PAR VALUE 03/31/2026 0001636651 OVID THERAPEUTICS INC. 690469101 441 Ninth Avenue 14th Floor New York NY 10001 Rule 13d-1(d) Jeremy M. Levin b X1 8551502.00 0.00 8551502.00 0.00 8551502.00 4.5 IN OVID THERAPEUTICS INC. 441 Ninth Avenue, 14th Floor, New York, NY, 10001. Jeremy M. Levin (the "Reporting Person") c/o Ovid Therapeutics Inc. 441 Ninth Avenue, 14th Floor New York, New York 10001 United States of America Y As of the date hereof, the Reporting Person beneficially owns 8,551,502 shares of the Issuer's common stock, which consists of (i) 3,735,048 shares of the Issuer's common stock held directly by the Reporting Person, (ii) 35,461 shares held by Divo Holdings, LLC, a limited liability company managed by the Reporting Person's spouse, (iii) 35,500 shares of common stock issuable upon exercise of Series B warrants, and (iv) 4,745,493 shares of common stock issuable upon the exercise of stock options within 60 days of March 31, 2026. As of the date hereof, the Reporting Person holds 4.5% of the Issuer's common stock. This percentage is calculated based upon 186,640,102 outstanding shares of the Issuer's common stock, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (Commission File No. 001-38085) filed with the Securities and Exchange Commission on May 12, 2026. 8,551,502 shares 0 8,551,502 shares 0 N Y Y Y Y Y Y Jeremy M. Levin /s/ Jeremy M. Levin 05/14/2026